Preferred Stock And Warrant Purchase Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Preferred Stock and Warrant Purchase Agreement (May 5th, 2017)

THIS PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT ("Agreement") is made as of the ____ day of _______________ 2017 by and among Visualant, Incorporated, a Nevada corporation (the "Company"), and the Investor(s) set forth on the signature pages affixed hereto (each an "Investor" and collectively the "Investors").

Visterra, Inc. – SERIES C CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT VISTERRA, INC. June 29, 2016 (January 17th, 2017)

This Series C Convertible Preferred Stock and Warrant Purchase Agreement dated as of June 29, 2016 (this Agreement) is made by and among (i) Visterra, Inc., a Delaware corporation (the Company), (ii) the persons and entities listed on Schedule 1 hereto (each individually, a Purchaser and collectively, the Purchasers), (iii) solely for the purposes of Sections 6 through 11 of this Agreement, the Preferred Holders (as defined in Section 8.1 below) who are not Purchasers, and, (iv) solely for the purposes of Sections 8 through 11 of this Agreement, the Founder Holders (as defined in Section 8.1 below), who are not Purchasers.

Preferred Stock and Warrant Purchase Agreement (December 23rd, 2016)

THIS PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT ("Agreement") is made as of the 19th day of December, 2016 by and among Visualant, Incorporated, a Nevada corporation (the "Company"), and the Investor(s) set forth on the signature pages affixed hereto (each an "Investor" and collectively the "Investors").

Preferred Stock and Warrant Purchase Agreement (November 18th, 2016)

THIS PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT ("Agreement") is made as of the 10th day of November, 2016 by and among Visualant, Incorporated, a Nevada corporation (the "Company"), and the Investor(s) set forth on the signature pages affixed hereto (each an "Investor" and collectively the "Investors").

Visterra, Inc. – SERIES C CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT VISTERRA, INC. June 29, 2016 (November 9th, 2016)

This Series C Convertible Preferred Stock and Warrant Purchase Agreement dated as of June 29, 2016 (this Agreement) is made by and among (i) Visterra, Inc., a Delaware corporation (the Company), (ii) the persons and entities listed on Schedule 1 hereto (each individually, a Purchaser and collectively, the Purchasers), (iii) solely for the purposes of Sections 6 through 11 of this Agreement, the Preferred Holders (as defined in Section 8.1 below) who are not Purchasers, and, (iv) solely for the purposes of Sections 8 through 11 of this Agreement, the Founder Holders (as defined in Section 8.1 below), who are not Purchasers.

Capstone Therapeutics – Lipimetix Development, Inc. Series B Preferred Stock and Warrant Purchase Agreement (August 26th, 2016)

This Series B Preferred Stock AND WARRANT Purchase Agreement (this "Agreement") is made and entered into as of August 25, 2016, by and among LipimetiX Development, Inc., a Delaware corporation (the "Company"), and the investors set forth on Exhibit A attached to this Agreement (each, a "Purchaser" and collectively, the "Purchasers").

Form of Preferred Stock and Warrant Purchase Agreement (August 11th, 2016)

THIS PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT ("Agreement") is made as of the ____ day of August, 2016 by and among Visualant, Incorporated, a Nevada corporation (the "Company"), and the Investor(s) set forth on the signature pages affixed hereto (each an "Investor" and collectively the "Investors").

MyDx, Inc. – Series B Preferred Stock and Warrant Purchase Agreement (May 5th, 2015)

THIS SERIES B PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of October [___], 2014, by and among CDx, Inc., a Delaware corporation (the "Company"), and the investors ("Investors") listed on Schedule I hereto (the "Schedule of Investors").

Ritter Pharmaceuticals Inc – Ritter Pharmaceuticals, Inc. Series C Preferred Stock and Warrant Purchase Agreement (March 23rd, 2015)

This Series C Preferred Stock and Warrant Purchase Agreement (the "Agreement") is made as of December 4, 2014, by and among Ritter Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and those investors listed on Exhibit A hereto, each of which is herein referred to as an "Investor."

Great Basin Scientific, Inc. Series D Preferred Stock and Warrant Purchase Agreement (August 20th, 2014)

THIS AMENDED AND RESTATED SERIES D PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this Agreement) is made as of the 30th day of July, 2014 by and among Great Basin Scientific, Inc., a Delaware corporation (the Company), and the investors, severally and not jointly, listed on Schedule 1 hereto, each of which is herein referred to as an Investor.

Series E Preferred Stock and Warrant Purchase Agreement (June 19th, 2014)

This Series E Preferred Stock and Warrant Purchase Agreement, dated as of June 13, 2013 (this Agreement), is entered into by and among Roka Bioscience, Inc., a Delaware corporation (the Company), and the several purchasers named in Attachment 1 attached hereto (each a Purchaser and collectively, the Purchasers).

Glori Energy Inc. – Series C-2 Preferred Stock and Warrant Purchase Agreement (May 2nd, 2014)

THIS SERIES C-2 PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the "Agreement") is entered into as of March 13, 2014, by and among Glori Energy Inc. (f/k/a Glori Oil Limited), a Delaware corporation (the "Company"), and the purchasers listed on Exhibit A attached hereto (each a "Purchaser" and collectively, the "Purchasers").

Glori Energy Inc. – Series C-2 Preferred Stock and Warrant Purchase Agreement (April 18th, 2014)

THIS SERIES C-2 PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the "Agreement") is entered into as of March 13, 2014, by and among Glori Energy Inc. (f/k/a Glori Oil Limited), a Delaware corporation (the "Company"), and the purchasers listed on Exhibit A attached hereto (each a "Purchaser" and collectively, the "Purchasers").

Glori Energy Inc. – Series C-1 Preferred Stock and Warrant Purchase Agreement (April 18th, 2014)

THIS SERIES C-1 PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the "Agreement") is entered into as of this 30th day of April, 2013, by and among Glori Energy Inc. (f/k/a Glori Oil Limited), a Delaware corporation (the "Company"), and the purchasers listed from time to time on Exhibit A attached hereto (each a "Purchaser" and collectively, the "Purchasers").

Radius Health, Inc. – Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (April 3rd, 2014)

This Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 14th day of February, 2014, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Radius Health, Inc. – Series B Convertible Preferred Stock and Warrant Purchase Agreement (April 3rd, 2014)

This Series B Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 23rd day of April, 2013, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Radius Health, Inc. – Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (April 3rd, 2014)

This Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 14th day of February, 2014, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Radius Health, Inc. – Series B Convertible Preferred Stock and Warrant Purchase Agreement (April 3rd, 2014)

This Series B Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 23rd day of April, 2013, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Radius Health, Inc. – Amendment No. 1 to Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (April 1st, 2014)

This Amendment No. 1, dated as of March 28, 2014 (the Amendment), by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the Series B-2 Majority Investors, amends that certain Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement, dated February 14, 2014, by and among the Corporation and the Investors referenced therein (the Agreement). Capitalized terms used in this Amendment without definition shall have the same meaning as set forth in the Agreement unless otherwise indicated.

Radius Health, Inc. – Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (February 21st, 2014)

This Series B-2 Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 14th day of February, 2014, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Lime Energy Co. Preferred Stock and Warrant Purchase Agreement (February 3rd, 2014)

This Preferred Stock And Warrant Purchase Agreement (this Agreement) is dated and effective as of January 29, 2014, by and among Lime Energy Co., a Delaware corporation (the Company), and the investors listed on Schedule 2.2 of this Agreement (each, a Purchaser and collectively, the Purchasers).

Series E Preferred Stock and Warrant Purchase Agreement (January 23rd, 2014)

This Series E Preferred Stock and Warrant Purchase Agreement, dated as of June 13, 2013 (this Agreement), is entered into by and among Roka Bioscience, Inc., a Delaware corporation (the Company), and the several purchasers named in Attachment 1 attached hereto (each a Purchaser and collectively, the Purchasers).

Lime Energy Co. Preferred Stock and Warrant Purchase Agreement (December 31st, 2013)

This Preferred Stock And Warrant Purchase Agreement (this Agreement) is dated and effective as of December 30, 2013, by and among Lime Energy Co., a Delaware corporation (the Company), and the investors listed on Schedule 2.2 of this Agreement (each, a Purchaser and collectively, the Purchasers).

Series E Convertible Preferred Stock and Warrant Purchase Agreement (October 3rd, 2013)

THIS SERIES E CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Agreement) is made as of June 10, 2010 by and among Acceleron Pharma Inc., a Delaware corporation (the Corporation) and the investors that are named on the Initial Closing Schedule of Investors and Additional Closing Schedule of Investors attached hereto (the Investors).

Lime Energy Co. Preferred Stock and Warrant Purchase Agreement (September 23rd, 2013)

This Preferred Stock And Warrant Purchase Agreement (this Agreement) is dated and effective as of September 23, 2013, by and among Lime Energy Co., a Delaware corporation (the Company), and the investors listed on Schedule 2.2 of this Agreement (each, a Purchaser and collectively, the Purchasers).

Radius Health, Inc. – Series B Convertible Preferred Stock and Warrant Purchase Agreement (April 25th, 2013)

This Series B Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement), dated this 23rd day of April, 2013, is entered into by and among Radius Health, Inc., a Delaware corporation (the Corporation), and the persons listed on Schedule I attached hereto (the Investors, and each individually, an Investor).

Idera Pharmaceuticals – IDERA PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT November 9, 2012 (November 14th, 2012)

This Convertible Preferred Stock and Warrant Purchase Agreement (this AGREEMENT) is entered into as of the date set forth above by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the COMPANY), and the undersigned purchasers (each a PURCHASER and collectively, the PURCHASERS) set forth on the Schedule of Purchasers attached hereto as Exhibit A (the SCHEDULE OF PURCHASERS). The parties hereby agree as follows:

Idera Pharmaceuticals – Idera Pharmaceuticals, Inc. Amendment No. 1 to Convertible Preferred Stock and Warrant Purchase Agreement (November 14th, 2012)

This Amendment No. 1 to Convertible Preferred Stock and Warrant Purchase Agreement (this Agreement) is made as of November 9, 2012, by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the Company), and Pillar Pharmaceuticals I, L.P. (the Purchaser).

Access Pharmaceuticals Inc. – PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and Among Access Pharmaceuticals, Inc. And the Parties Named Herein on Schedule 1, as Purchasers October 25, 2012 (October 26th, 2012)
Lifelock, Inc. Series E and Series E-2 Preferred Stock and Warrant Purchase Agreement (August 28th, 2012)

This Series E and Series E-2 Preferred Stock and Warrant Purchase Agreement (the Agreement) is made as of the 7th day of February, 2012 by and among LifeLock, Inc., a Delaware corporation (the Company), and each of the purchasers named on Exhibit A attached hereto (each, a Purchaser, and together, the Purchasers).

Series C Preferred Stock and Warrant Purchase Agreement (April 4th, 2012)

THIS SERIES C PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of the 3rd day of April, 2012, by and between VirtualScopics, Inc., a Delaware corporation (the "Company"), with a principal place of business at 500 Linden Oaks, Rochester, New York 14625, and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company (the "Purchaser"), with a principal place of business at One Merck Drive, Whitehouse Station, New Jersey 08889-0100.

Idera Pharmaceuticals – IDERA PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT November 4, 2011 (November 10th, 2011)

This Convertible Preferred Stock and Warrant Purchase Agreement (this AGREEMENT) is entered into as of the date set forth above by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the COMPANY), and the undersigned purchasers (each a PURCHASER and collectively, the PURCHASERS) set forth on the Schedule of Purchasers attached hereto as Exhibit A (the SCHEDULE OF PURCHASERS). The parties hereby agree as follows:

Exa Corporation – Exa Corporation Series a Preferred Stock and Warrant Purchase Agreement (August 3rd, 2011)

This CLASS A PREFERRED STOCK AND COMMON STOCK PURCHASE AGREEMENT (the Agreement) is made this 30th day of April, 1993 by and among Exa Corporation, a Massachusetts corporation (the Company) and Fidelity Ventures Ltd. (Fidelity), Philip A. Cooper, Robert S. Kniffin, Kim Molvig and Stephen A. Remondi (the Investors).

Exa Corporation – Exa Corporation Series B Preferred Stock and Warrant Purchase Agreement (August 3rd, 2011)

This CLASS B PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the Agreement) is made this 2nd day of November, 1994 by and among Exa Corporation, a Massachusetts corporation (the Company) and Fidelity Ventures Ltd. (Fidelity), Boston Capital Ventures III, Limited Partnership (BCV), Edelson Technology Partners (Edelson), Massachusetts Capital Resource Company (MCRC), Associated Group, Inc. (Associated), John J. Shields, III and John William Poduska (collectively, the Investors).

Players Network Series B Preferred Stock and Warrant Purchase Agreement (December 23rd, 2010)

This SERIES B PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of the 17th day of December, 2010 between Players Network, a Nevada corporation (the "Company"), and Tice Capital, LLC, a Texas limited liability company(the "Purchaser").